Moderna Begins Phase 1 Trial for Ebola mRNA Vaccine
Cambridge, Massachusetts – August 4, 2026 Moderna, Inc. has announced the initiation of a Phase 1 clinical trial evaluating...
Manufacturing
Advertisement
Integer to Be Acquired by KKR in $5.7 Billion Deal
Plano, Texas & New York – August 3, 2026 Integer Holdings Corporation, one of the world’s largest medical device...
Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar
HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
Regentis Wins European Approval for New GelrinC Process
HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...
Telix Opens Australia’s First Integrated Radiopharmaceutical Facility for Cancer Care
MELBOURNE, Australia & INDIANAPOLIS, Ind., July 16, 2026 Telix has officially opened Telix Manufacturing Solutions North Melbourne (TMSNM), Australia’s...
Advertisements
IntelliGenome Wins INVIMA Approval for CRISPR-TB Test
HOUSTON, Texas & BOGOTÁ, Colombia, June 29, 2026 IntelliGenome, Inc. has received sanitary registration approval from Colombia’s National Institute...
CraniUS Therapeutics Wins NIH Award for NeuroPASS Platform
BALTIMORE, Maryland, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of...
M&M International Acquires KC Tech to Expand MedTech Portfolio
STAMFORD, Connecticut, June 30, 2026 Gainline Capital Partners has announced that its portfolio company M&M International, a leading manufacturer...
Sobi Receives FDA Complete Response Letter for NASP BLA
STOCKHOLM, Sweden, June 26, 2026 Sobi announced that it has received a Complete Response Letter (CRL) from the U.S....
Thermo Fisher Launches Compleo System for Cell Therapy
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
Advertisement
